Brent Eck
Director/Miembro de la Junta en KinDex Pharmaceuticals, Inc. .
Perfil
Brent Eck is currently a Director at KinDex Pharmaceuticals, Inc. Prior to his current position, he served as the President & Chief Executive Officer at Metagenics LLC from 2015 to 2023.
Mr. Eck received his undergraduate degree from Loyola University of Chicago.
Cargos activos de Brent Eck
| Empresas | Cargo | Inicio |
|---|---|---|
KinDex Pharmaceuticals, Inc.
 KinDex Pharmaceuticals, Inc. BiotechnologyHealth Technology Kindex Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on discovering and developing of novel therapeutics for the treatment of metabolic. The company is headquartered in Boston, MA. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Brent Eck.
| Empresas | Cargo | Fin |
|---|---|---|
Metagenics LLC
 Metagenics LLC Pharmaceuticals: OtherHealth Technology Metagenics, Inc. provides nutritional supplements, medical foods and nutraceuticals for health care professionals. The company was founded in 1983 and is headquartered in San Clemente, CA. | Director Ejecutivo | 13/02/2023 |
Formación de Brent Eck.
| Loyola University of Chicago | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Metagenics LLC
Metagenics LLC Pharmaceuticals: OtherHealth Technology Metagenics, Inc. provides nutritional supplements, medical foods and nutraceuticals for health care professionals. The company was founded in 1983 and is headquartered in San Clemente, CA. | Health Technology |
KinDex Pharmaceuticals, Inc.
KinDex Pharmaceuticals, Inc. BiotechnologyHealth Technology Kindex Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on discovering and developing of novel therapeutics for the treatment of metabolic. The company is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Brent Eck
